Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Qiagen Inc
    Registered Vendor
    • Dec 2015
    • 3

    #1

    Senior Scientist, Enzyme Engineering (NGS)

    Senior Scientist, Enzyme Engineering, NGS Technologies will be responsible for the development of novel improved enzymes that will be used in Qiagen’s NGS workflows. These enzymes include sequencing enzymes for the sequencing by synthesis processes as well as novel enzymes used for nucleic acids amplification. In this role Senior Scientist, Enzyme Engineering will focus on near and long term improvements to existing Gene Reader workflows as well as perform research on novel internal and external technologies which will expand the range of applications and capabilities supported by future NGS workflows/platforms. The position will have a key role in bringing innovative solutions to current and future NGS platforms and expanding the range of applications served by these platforms. Senior Scientist will be working closely with Sample Prep and Sequencing teams as well as Engineering to ensure seamless integration of novel enzymes into QIAGEN’s NGS portfolio.

    In this role Senior Scientist, Enzyme Engineering, NGS Technologies will:


    Investigate and develop technologies and approaches (internal and external) to the development of novel sequencing enzymes with improved properties including mutagenesis, in silico design and in vitro evolution which significantly improve performance and capabilities of the Gene Reader workflows

    Work closely with Sequencing Chemistry developers to integrate novel sequencing enzymes into the Gene Reader workflows

    Evaluate external technologies and engage in external collaborations to bring novel technologies to QIAGEN’s NGS portfolio

    Play a key role in the development of future improvements, technological advances in the QIAGEN NGS platform and expansion of intellectual property

    Participate in collaborations with key external partners (industry and academia)

    Mentor and develop staff

    Deliver key insights into product application opportunities for the Qiagen's NGS platforms

    REQUIREMENTS

    PhD in Biology, Chemistry, Biochemistry, Bioengineering or related fields
    At least 5-10 years of relevant industry experience (NGS and adjacent technologies)

    Extensive experience with protein engineering based on rational design, mutagenesis, in silico design, and enzyme in vitro evolution

    Experience with protein purification and enzymatic activity measurements/ assays

    Experience with diagnostic assay development and regulatory environment is a plus

    Excellent understanding of the underlying technical principles of next generation sequencing chemistries and workflows, associated instrumentation platforms and data analysis and interpretation algorithms

    Mandatory experience in next generation sequencing (NGS) technology development (DNA amplification, sample preparation, chemistry, instrumentation)

    Very good troubleshooting and problem solving skills

    Proven leadership and successful decision-making qualities

    Strong technical writing and presentation skills

    Moderate travel required (up to 10%)


    To apply, please follow the link below



    Qiagen is an Equal Opportunity Employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity, status as a veteran, and basis of disability or any other federal, state or local protected class.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...